Buprenorphine implant - Molteni/Titan Pharmaceuticals
At a glance
- Drug Originator Titan Pharmaceuticals
- Drug Licenced by Accord Healthcare; Knight Therapeutics; Molteni Farmaceutici
- Drug Class Cyclopropanes; Drug withdrawal therapies; Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Nociceptin receptor agonists; Opioid delta receptor agonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists
- USA Patent Applicants REACX PHARMS
- USA Patents 1
- NDAs 1
- Patent Applications 3,749
Table of Contents

Disclaimer